- Home
- NEUE vs CARM Comparison
NEUE vs CARM Comparison
Compare NEUE & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUE
- CARM
- Stock Information
- Founded
- NEUE 2015
- CARM 2016
- Country
- NEUE United States
- CARM United States
- Employees
- NEUE N/A
- CARM N/A
- Industry
- NEUE
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- NEUE
- CARM Health Care
- Exchange
- NEUE NYSE
- CARM Nasdaq
- Market Cap
- NEUE 41.6M
- CARM 41.5M
- IPO Year
- NEUE 2021
- CARM N/A
- Fundamental
- Price
- NEUE $5.00
- CARM $0.88
- Analyst Decision
- NEUE Hold
- CARM Strong Buy
- Analyst Count
- NEUE 1
- CARM 3
- Target Price
- NEUE $8.00
- CARM $12.67
- AVG Volume (30 Days)
- NEUE 8.7K
- CARM 191.3K
- Earning Date
- NEUE 11-07-2024
- CARM 11-07-2024
- Dividend Yield
- NEUE N/A
- CARM N/A
- EPS Growth
- NEUE N/A
- CARM N/A
- EPS
- NEUE N/A
- CARM N/A
- Revenue
- NEUE $996,890,000.00
- CARM $20,268,000.00
- Revenue This Year
- NEUE N/A
- CARM $50.40
- Revenue Next Year
- NEUE $10.49
- CARM N/A
- P/E Ratio
- NEUE $1.47
- CARM N/A
- Revenue Growth
- NEUE N/A
- CARM 41.13
- 52 Week Low
- NEUE $4.66
- CARM $0.80
- 52 Week High
- NEUE $16.59
- CARM $3.16
- Technical
- Relative Strength Index (RSI)
- NEUE 46.19
- CARM 34.30
- Support Level
- NEUE $4.66
- CARM $0.96
- Resistance Level
- NEUE $5.24
- CARM $1.01
- Average True Range (ATR)
- NEUE 0.34
- CARM 0.06
- MACD
- NEUE -0.01
- CARM -0.01
- Stochastic Oscillator
- NEUE 39.53
- CARM 8.59
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.